Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cap-SPGAS: Capsaicin Oral Film in Acute Ischemic Stroke
NCT07406971Phase 2Recruiting
- Sponsor
- Instituto Mexicano del Seguro Social
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cauterex in ischemic stroke, sponsored by Instituto Mexicano del Seguro Social. Started Sep 2025; status: recruiting.
02
Drugs
Cauterex
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07406971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07406971.